| 72 | Systemic administration
of IL-15 augments primary T cell response to vaccination Mark P. Rubinstein, Andre N. Kadima, Mohamed L. Salem, Christophe L. Nguyen, William E. Gillanders, and David J. Cole Medical University of South Carolina; Charleston, SC |
| 73 | Prolactin Promotes
Mammary Tumor Growth in C3(1)/SV40 Large T-Antigen Transgenic
Mice Welniak, Lisbeth1; Hixon, Julie2; Richards, Susan3; Green, Jeffrey4; Murphy, William2 1Laboratory of Molecular Immunoregulation, National Cancer Institute – Frederick, Frederick, MD; 2IRSP, SAIC, NCI- Frederick Frederick, MD; 3Genzyme Corporation Framingham, MA; 4LCRC, National Cancer Institute Bethesda, MD |
| 74 | Down modulation of
host innate immune responses by RanC/d with adenoviral gene
therapy Peter M C Wong, John A Arnott & Siu-Wah Chung Department of Pathology & Laboratory Medicine, Fels Institute of Cancer Research & Molecular Biology, Temple University School of Medicine, Philadelphia, PA |
| 75 | Therapeutic efficacy
of vitamin D3-binding protein-derived macrophage activating
factor for prostate, breast and colon cancer Nobuto Yamamoto1, Masahiro Urade2, Hirofumi Suyama3, and Hiroaki Nakazato4 1Socrates Institute for Therapeutic Immunology, Philadelphia, PA; 2Hyogo College of Medicine, Hyogo; 3Nagasaki University, Nagasaki; and 4Yokoyama Hospital, Nagoya, Japan |
| 76 | Delayed in vivo growth
of Lewis lung carcinoma cells that have been genetically engineered
to secrete the kringle 5 domain of plasminogen Hiroshi Yazawa1, Philip G. Roessler1, Robert H. Wiltrout1 and Morihiro Watanabe1 1Laboratory of Experimental Immunology, NCI Center for Cancer Research, Frederick, MD |
| 77 | Tumor-lytic CD28-CD8+
T Cells Circulating in Patients with Ewing’s Sarcoma Derive
Requisite Co-stimulation by Tumor Expression of 4-1BBL Hua Zhang1, Kevin S Chua1, Chand Khanna2, Lee J Helman2 and Crystal L Mackall1 1Immunology Section, 2Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD |
| 78 | Novel Method to Simplify
Detection and Functional Analysis of Antigen-Specific T cells H-M. Hu, A. Dols, S.L. Meijer, J.W. Smith III, W.J. Urba, E. Walker, B.A.Fox R.W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR |
| 79 | Identification of a New Candidate
HLA-A3 Restricted CMV Epitope as a Target Antigen to induce
specific CMV Cytotoxic T Lymphocyte Jong-Baeck Lim, Maurizio Provenzano, Maria Bettinotti and David Stroncek Department of Transfusion Medicine, Clinical Center, National Institute of Health, Bethesda, MD |
| 80 | Novel naturally processed MHC
class I-bound peptides from ovarian and prostate cancer identified
by mass spectrometry Venky Ramakrishna, Helen Myers, Melanie McDaniel and Ramila Philip Argonex Inc., Charlottesville, VA 22903 |
| 81 | Anti-tumor Effects
of Liposomal IL-2 in an MCA 38 Colon Liver Metastases Tumor
Model Mary H Ryan, Mary E Neville, Chad Hubbard, Richard J Robb and Mircea C Popescu Biomira USA Inc., Cranbury NJ |
